Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Duflot

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Drug Testing and Analysis|July 2, 2019
Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disordersThomas Duflot, Marianne Vasse, Jennifer Guillerme, et al.
Journal of Hypertension|April 26, 2017
Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factorsJérémy Bellien, Michèle Iacob, Christelle Monteil, et al.
International Journal of Molecular Sciences|June 21, 2020
The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular CalcificationOlivier Varennes, Romuald Mentaverri, Thomas Duflot, et al.
Analytical and Bioanalytical Chemistry|December 17, 2016
A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulationThomas Duflot, Tony Pereira, Clothilde Roche, et al.
International Journal of Antimicrobial Agents|January 19, 2016
Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infectionsFabien Lamoureux, Thomas Duflot, Jean-Baptiste Woillard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 20, 2025
Population pharmacokinetics of cefazolin in neurosurgical antibiotic prophylaxisJulien Scala-Bertola, David Rouget, Maxime Riffault, et al.
Prostaglandins & Other Lipid Mediators|May 30, 2015
Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight miceClothilde Roche, Dominique Guerrot, Najah Harouki, et al.
Metabolites|November 25, 2021
Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?Thomas Duflot, Ly Tu, Matthieu Leuillier, et al.
Frontiers in Medicine|June 21, 2021
Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 InfectionPaul Billoir, Kevin Alexandre, Thomas Duflot, et al.
The AAPS Journal|February 26, 2025
Unraveling Ceftriaxone Dosing: Free Drug Prediction, Threshold Optimization, and Model ValidationJohnny Michel, Francesco Monti, Fabien Lamoureux, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Drug Testing and Analysis|July 2, 2019
Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disordersThomas Duflot, Marianne Vasse, Jennifer Guillerme, et al.
Journal of Hypertension|April 26, 2017
Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factorsJérémy Bellien, Michèle Iacob, Christelle Monteil, et al.
International Journal of Molecular Sciences|June 21, 2020
The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular CalcificationOlivier Varennes, Romuald Mentaverri, Thomas Duflot, et al.
Analytical and Bioanalytical Chemistry|December 17, 2016
A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulationThomas Duflot, Tony Pereira, Clothilde Roche, et al.
International Journal of Antimicrobial Agents|January 19, 2016
Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infectionsFabien Lamoureux, Thomas Duflot, Jean-Baptiste Woillard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 20, 2025
Population pharmacokinetics of cefazolin in neurosurgical antibiotic prophylaxisJulien Scala-Bertola, David Rouget, Maxime Riffault, et al.
Prostaglandins & Other Lipid Mediators|May 30, 2015
Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight miceClothilde Roche, Dominique Guerrot, Najah Harouki, et al.
Metabolites|November 25, 2021
Preventing the Increase in Lysophosphatidic Acids: A New Therapeutic Target in Pulmonary Hypertension?Thomas Duflot, Ly Tu, Matthieu Leuillier, et al.
Frontiers in Medicine|June 21, 2021
Investigation of Coagulation Biomarkers to Assess Clinical Deterioration in SARS-CoV-2 InfectionPaul Billoir, Kevin Alexandre, Thomas Duflot, et al.
The AAPS Journal|February 26, 2025
Unraveling Ceftriaxone Dosing: Free Drug Prediction, Threshold Optimization, and Model ValidationJohnny Michel, Francesco Monti, Fabien Lamoureux, et al.
Pageof 5